HLB BioStep Co (278650.KQ) Stock Price
HLB BioStep Co Price
Over the last 9 years HLB BioStep Co grew revenue by 23.4% annually, reaching 74.05 B KRW. Earnings per share have grown at 23.6% per year over the last 5 years. For HLB BioStep Co, the net margin of -25.6% is down versus 17.1% a few years ago. At today's price the dividend yield works out to roughly 2.29%. The payout ratio is around 70% of earnings. The dividend has grown at 15.5% per year over the past 2 years.
HLB BioStep Co stock price
HLB BioStep Co business model & stock analysis
Frequently asked questions about HLB BioStep Co
Converted at the current exchange rate, the HLB BioStep Co share trades at 3.24 EUR (4,855.00 KRW).
The revenue cannot currently be calculated for HLB BioStep Co.
The profit cannot currently be calculated for HLB BioStep Co.
The P/E ratio cannot be calculated for HLB BioStep Co at the moment.
The P/S cannot be calculated for HLB BioStep Co currently.
The Eulerpool Quality Score for HLB BioStep Co is 0/10.
The ISIN of HLB BioStep Co is KR7278650007. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of HLB BioStep Co is 278650.KQ. The ticker symbol is used to trade HLB BioStep Co shares on the stock exchange.
HLB BioStep Co stock
HLB BioStep Co Peer Group
HLB BioStep Co FIGI
All fundamentals and in-depth analysis of HLB BioStep Co
Our stock analysis for HLB BioStep Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of HLB BioStep Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.